Qualigen Therapeutics Stock Forecast, Price & News

Qualigen Therapeutics (NASDAQ:QLGN) Frequently Asked Questions

Is Qualigen Therapeutics a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Qualigen Therapeutics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Qualigen Therapeutics stock.
View analyst ratings for Qualigen Therapeutics or view top-rated stocks.

Are investors shorting Qualigen Therapeutics?

Qualigen Therapeutics saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 2,410,000 shares, an increase of 33.9% from the December 15th total of 1,800,000 shares. Based on an average trading volume of 8,480,000 shares, the short-interest ratio is presently 0.3 days. Currently, 9.3% of the company's stock are short sold.
View Qualigen Therapeutics' Short Interest.

When is Qualigen Therapeutics' next earnings date?

Qualigen Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, February 21st 2022.
View our earnings forecast for Qualigen Therapeutics.

How were Qualigen Therapeutics' earnings last quarter?

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.20) by $0.10. The company earned $1.16 million during the quarter, compared to the consensus estimate of $1.50 million.
View Qualigen Therapeutics' earnings history.

What price target have analysts set for QLGN?

1 brokers have issued twelve-month price targets for Qualigen Therapeutics' shares. Their forecasts range from $6.50 to $6.50. On average, they expect Qualigen Therapeutics' stock price to reach $6.50 in the next year. This suggests a possible upside of 519.0% from the stock's current price.
View analysts' price targets for Qualigen Therapeutics or view top-rated stocks among Wall Street analysts.

Who are Qualigen Therapeutics' key executives?

Qualigen Therapeutics' management team includes the following people:

• Michael S. Poirier, Chairman & Chief Executive Officer
• Amy Broidrick, President, Director & Chief Strategy Officer (LinkedIn Profile)
• Shishir K. Sinha, Chief Operating Officer, Secretary & VP
• Christopher L. Lotz, Chief Financial Officer & Vice President
• Wajdi Abdul-Ahad, Chief Scientific Officer & Vice President-R&D

Who are some of Qualigen Therapeutics' key competitors?

Some companies that are related to Qualigen Therapeutics include Ainos (AIMD), Galectin Therapeutics (GALT), Viracta Therapeutics (VIRX), Decibel Therapeutics (DBTX), Otonomy (OTIC), Esperion Therapeutics (ESPR), Puma Biotechnology (PBYI), ProPhase Labs (PRPH), Avalo Therapeutics (AVTX), iBio (IBIO), scPharmaceuticals (SCPH), BioVie (BIVI), Concert Pharmaceuticals (CNCE), Oncorus (ONCR) and Zynerba Pharmaceuticals (ZYNE).
View all of QLGN's competitors.

What other stocks do shareholders of Qualigen Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Qualigen Therapeutics investors own include iBio (IBIO), Boeing (BA), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), NIO (NIO), NVIDIA (NVDA), Riot Blockchain (RIOT), Vaxart (VXRT), Boxlight (BOXL) and Enphase Energy (ENPH).

What is Qualigen Therapeutics' stock symbol?

Qualigen Therapeutics trades on the NASDAQ under the ticker symbol "QLGN."

How do I buy shares of Qualigen Therapeutics?

Shares of QLGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Qualigen Therapeutics' stock price today?

One share of QLGN stock can currently be purchased for approximately $1.05.

How much money does Qualigen Therapeutics make?

Qualigen Therapeutics has a market capitalization of $30.88 million.

How many employees does Qualigen Therapeutics have?

Qualigen Therapeutics employs 36 workers across the globe.

What is Qualigen Therapeutics' official website?

The official website for Qualigen Therapeutics is www.qualigeninc.com.

Where are Qualigen Therapeutics' headquarters?

Qualigen Therapeutics is headquartered at 2042 Corte Del Nogal, Carlsbad CA, 92011.

How can I contact Qualigen Therapeutics?

Qualigen Therapeutics' mailing address is 2042 Corte Del Nogal, Carlsbad CA, 92011. The company can be reached via phone at (310) 203-1000 or via email at [email protected].